Selected research
Market Structure
Global Plant-based Soft Capsules (Softgel) Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global Plant-based Soft Capsules (Softgel) market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.
The US & Canada market for Plant-based Soft Capsules (Softgel) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Plant-based Soft Capsules (Softgel) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Plant-based Soft Capsules (Softgel) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for Plant-based Soft Capsules (Softgel) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Plant-based Soft Capsules (Softgel) include Catalent, Procaps Laboratorios, Eurocaps, Sirio Pharma (Best Formulations), Aenova, Captek, Bahrain Pharma, Robinson Pharma and Aland, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
This report provides an overview of the global Plant-based Soft Capsules (Softgel) market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Plant-based Soft Capsules (Softgel) and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Plant-based Soft Capsules (Softgel) sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Plant-based Soft Capsules (Softgel) market size, projected growth trends, production technologies, key applications, and end-use industries.
Plant-based Soft Capsules (Softgel) Segment by Company
Catalent
Procaps Laboratorios
Eurocaps
Sirio Pharma (Best Formulations)
Aenova
Captek
Bahrain Pharma
Robinson Pharma
Aland
Fuji Capsule
Sunsho Pharmaceutical
Erkang
Baihe Group
Plant-based Soft Capsules (Softgel) Segment by Type
Carrageenan
Starch
Gellan Gum
Plant-based Soft Capsules (Softgel) Segment by Application
Rx and OTC
Supplements
Other
Plant-based Soft Capsules (Softgel) Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Plant-based Soft Capsules (Softgel) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Plant-based Soft Capsules (Softgel) and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Plant-based Soft Capsules (Softgel).
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Plant-based Soft Capsules (Softgel) market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Plant-based Soft Capsules (Softgel) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Plant-based Soft Capsules (Softgel) in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Plant-based Soft Capsules (Softgel) in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Carrageenan
- Starch
- Gellan Gum
Applications
- Rx and OTC
- Supplements
- Other
Companies covered
- Catalent
- Procaps Laboratorios
- Eurocaps
- Sirio Pharma (Best Formulations)
- Aenova
- Captek
- Bahrain Pharma
- Robinson Pharma
- Aland
- Fuji Capsule
- Sunsho Pharmaceutical
- Erkang
- Baihe Group
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Plant-based Soft Capsules (Softgel) Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Plant-based Soft Capsules (Softgel) Market Size Estimates and Forecasts (2021-2032)
- 1.4 Global Plant-based Soft Capsules (Softgel) Sales Estimates and Forecasts (2021-2032)
- 1.5 Global Plant-based Soft Capsules (Softgel) Market Average Price (2021-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
2 Global Plant-based Soft Capsules (Softgel) Market Dynamics
- 2.1 Plant-based Soft Capsules (Softgel) Industry Trends
- 2.2 Plant-based Soft Capsules (Softgel) Industry Drivers
- 2.3 Plant-based Soft Capsules (Softgel) Industry Opportunities and Challenges
- 2.4 Plant-based Soft Capsules (Softgel) Industry Restraints
3 Plant-based Soft Capsules (Softgel) Market by Manufacturers
- 3.1 Global Plant-based Soft Capsules (Softgel) Revenue by Manufacturers (2021-2026)
- 3.2 Global Plant-based Soft Capsules (Softgel) Sales by Manufacturers (2021-2026)
- 3.3 Global Plant-based Soft Capsules (Softgel) Average Sales Price by Manufacturers (2021-2026)
- 3.4 Global Plant-based Soft Capsules (Softgel) Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Plant-based Soft Capsules (Softgel) Key Manufacturers Manufacturing Sites & Headquarters
- 3.6 Global Plant-based Soft Capsules (Softgel) Manufacturers, Product Type & Application
- 3.7 Global Plant-based Soft Capsules (Softgel) Manufacturers Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Plant-based Soft Capsules (Softgel) Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Plant-based Soft Capsules (Softgel) Players Market Share by Revenue in 2025
- 3.8.3 2025 Plant-based Soft Capsules (Softgel) Tier 1, Tier 2, and Tier 3
4 Plant-based Soft Capsules (Softgel) Market by Type
- 4.1 Plant-based Soft Capsules (Softgel) Type Introduction
- 4.1.1 Carrageenan
- 4.1.2 Starch
- 4.1.3 Gellan Gum
- 4.2 Global Plant-based Soft Capsules (Softgel) Sales by Type
- 4.2.1 Global Plant-based Soft Capsules (Softgel) Sales by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Plant-based Soft Capsules (Softgel) Sales by Type (2021-2032)
- 4.2.3 Global Plant-based Soft Capsules (Softgel) Sales Market Share by Type (2021-2032)
- 4.3 Global Plant-based Soft Capsules (Softgel) Revenue by Type
- 4.3.1 Global Plant-based Soft Capsules (Softgel) Revenue by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Plant-based Soft Capsules (Softgel) Revenue by Type (2021-2032)
- 4.3.3 Global Plant-based Soft Capsules (Softgel) Revenue Market Share by Type (2021-2032)
5 Plant-based Soft Capsules (Softgel) Market by Application
- 5.1 Plant-based Soft Capsules (Softgel) Application Introduction
- 5.1.1 Rx and OTC
- 5.1.2 Supplements
- 5.1.3 Other
- 5.2 Global Plant-based Soft Capsules (Softgel) Sales by Application
- 5.2.1 Global Plant-based Soft Capsules (Softgel) Sales by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Plant-based Soft Capsules (Softgel) Sales by Application (2021-2032)
- 5.2.3 Global Plant-based Soft Capsules (Softgel) Sales Market Share by Application (2021-2032)
- 5.3 Global Plant-based Soft Capsules (Softgel) Revenue by Application
- 5.3.1 Global Plant-based Soft Capsules (Softgel) Revenue by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Plant-based Soft Capsules (Softgel) Revenue by Application (2021-2032)
- 5.3.3 Global Plant-based Soft Capsules (Softgel) Revenue Market Share by Application (2021-2032)
6 Global Plant-based Soft Capsules (Softgel) Sales by Region
- 6.1 Global Plant-based Soft Capsules (Softgel) Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global Plant-based Soft Capsules (Softgel) Sales by Region (2021-2032)
- 6.2.1 Global Plant-based Soft Capsules (Softgel) Sales by Region (2021-2026)
- 6.2.2 Global Plant-based Soft Capsules (Softgel) Sales Forecasted by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Plant-based Soft Capsules (Softgel) Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.3.2 North America Plant-based Soft Capsules (Softgel) Sales by Country (2021-2032)
- 6.3.3 U.S.
- 6.3.4 Canada
- 6.3.5 Mexico
- 6.4 Europe
- 6.4.1 Europe Plant-based Soft Capsules (Softgel) Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.4.2 Europe Plant-based Soft Capsules (Softgel) Sales by Country (2021-2032)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Netherlands
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific Plant-based Soft Capsules (Softgel) Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.5.2 Asia Pacific Plant-based Soft Capsules (Softgel) Sales by Country (2021-2032)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 Southeast Asia
- 6.5.7 India
- 6.5.8 Australia
- 6.6 South America, Middle East and Africa
- 6.6.1 South America, Middle East and Africa Plant-based Soft Capsules (Softgel) Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.6.2 South America, Middle East and Africa Plant-based Soft Capsules (Softgel) Sales by Country (2021-2032)
- 6.6.3 Brazil
- 6.6.4 South Africa
- 6.6.5 Saudi Arabia
- 6.6.6 Turkey
- 6.6.6 Argentina
- 6.6.6 UAE
- 6.6.6 Egypt
- 6.6.6 Chile
7 Global Plant-based Soft Capsules (Softgel) Revenue by Region
- 7.1 Global Plant-based Soft Capsules (Softgel) Revenue by Region
- 7.1.1 Global Plant-based Soft Capsules (Softgel) Revenue by Region: 2021 VS 2025 VS 2032
- 7.1.2 Global Plant-based Soft Capsules (Softgel) Revenue by Region (2021-2026)
- 7.1.3 Global Plant-based Soft Capsules (Softgel) Revenue by Region (2027-2032)
- 7.1.4 Global Plant-based Soft Capsules (Softgel) Revenue Market Share by Region (2021-2032)
- 7.2 North America
- 7.2.1 North America Plant-based Soft Capsules (Softgel) Revenue (2021-2032)
- 7.2.2 North America Plant-based Soft Capsules (Softgel) Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.3 Europe
- 7.3.1 Europe Plant-based Soft Capsules (Softgel) Revenue (2021-2032)
- 7.3.2 Europe Plant-based Soft Capsules (Softgel) Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.4 Asia-Pacific
- 7.4.1 Asia-Pacific Plant-based Soft Capsules (Softgel) Revenue (2021-2032)
- 7.4.2 Asia-Pacific Plant-based Soft Capsules (Softgel) Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.5 South America, Middle East and Africa
- 7.5.1 South America, Middle East and Africa Plant-based Soft Capsules (Softgel) Revenue (2021-2032)
- 7.5.2 South America, Middle East and Africa Plant-based Soft Capsules (Softgel) Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
- 8.1 Catalent
- 8.1.1 Catalent Company Information
- 8.1.2 Catalent Business Overview
- 8.1.3 Catalent Plant-based Soft Capsules (Softgel) Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.1.4 Catalent Plant-based Soft Capsules (Softgel) Product Portfolio
- 8.1.5 Catalent Recent Developments
- 8.2 Procaps Laboratorios
- 8.2.1 Procaps Laboratorios Company Information
- 8.2.2 Procaps Laboratorios Business Overview
- 8.2.3 Procaps Laboratorios Plant-based Soft Capsules (Softgel) Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.2.4 Procaps Laboratorios Plant-based Soft Capsules (Softgel) Product Portfolio
- 8.2.5 Procaps Laboratorios Recent Developments
- 8.3 Eurocaps
- 8.3.1 Eurocaps Company Information
- 8.3.2 Eurocaps Business Overview
- 8.3.3 Eurocaps Plant-based Soft Capsules (Softgel) Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.3.4 Eurocaps Plant-based Soft Capsules (Softgel) Product Portfolio
- 8.3.5 Eurocaps Recent Developments
- 8.4 Sirio Pharma (Best Formulations)
- 8.4.1 Sirio Pharma (Best Formulations) Company Information
- 8.4.2 Sirio Pharma (Best Formulations) Business Overview
- 8.4.3 Sirio Pharma (Best Formulations) Plant-based Soft Capsules (Softgel) Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.4.4 Sirio Pharma (Best Formulations) Plant-based Soft Capsules (Softgel) Product Portfolio
- 8.4.5 Sirio Pharma (Best Formulations) Recent Developments
- 8.5 Aenova
- 8.5.1 Aenova Company Information
- 8.5.2 Aenova Business Overview
- 8.5.3 Aenova Plant-based Soft Capsules (Softgel) Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.5.4 Aenova Plant-based Soft Capsules (Softgel) Product Portfolio
- 8.5.5 Aenova Recent Developments
- 8.6 Captek
- 8.6.1 Captek Company Information
- 8.6.2 Captek Business Overview
- 8.6.3 Captek Plant-based Soft Capsules (Softgel) Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.6.4 Captek Plant-based Soft Capsules (Softgel) Product Portfolio
- 8.6.5 Captek Recent Developments
- 8.7 Bahrain Pharma
- 8.7.1 Bahrain Pharma Company Information
- 8.7.2 Bahrain Pharma Business Overview
- 8.7.3 Bahrain Pharma Plant-based Soft Capsules (Softgel) Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.7.4 Bahrain Pharma Plant-based Soft Capsules (Softgel) Product Portfolio
- 8.7.5 Bahrain Pharma Recent Developments
- 8.8 Robinson Pharma
- 8.8.1 Robinson Pharma Company Information
- 8.8.2 Robinson Pharma Business Overview
- 8.8.3 Robinson Pharma Plant-based Soft Capsules (Softgel) Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.8.4 Robinson Pharma Plant-based Soft Capsules (Softgel) Product Portfolio
- 8.8.5 Robinson Pharma Recent Developments
- 8.9 Aland
- 8.9.1 Aland Company Information
- 8.9.2 Aland Business Overview
- 8.9.3 Aland Plant-based Soft Capsules (Softgel) Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.9.4 Aland Plant-based Soft Capsules (Softgel) Product Portfolio
- 8.9.5 Aland Recent Developments
- 8.10 Fuji Capsule
- 8.10.1 Fuji Capsule Company Information
- 8.10.2 Fuji Capsule Business Overview
- 8.10.3 Fuji Capsule Plant-based Soft Capsules (Softgel) Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.10.4 Fuji Capsule Plant-based Soft Capsules (Softgel) Product Portfolio
- 8.10.5 Fuji Capsule Recent Developments
- 8.11 Sunsho Pharmaceutical
- 8.11.1 Sunsho Pharmaceutical Company Information
- 8.11.2 Sunsho Pharmaceutical Business Overview
- 8.11.3 Sunsho Pharmaceutical Plant-based Soft Capsules (Softgel) Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.11.4 Sunsho Pharmaceutical Plant-based Soft Capsules (Softgel) Product Portfolio
- 8.11.5 Sunsho Pharmaceutical Recent Developments
- 8.12 Erkang
- 8.12.1 Erkang Company Information
- 8.12.2 Erkang Business Overview
- 8.12.3 Erkang Plant-based Soft Capsules (Softgel) Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.12.4 Erkang Plant-based Soft Capsules (Softgel) Product Portfolio
- 8.12.5 Erkang Recent Developments
- 8.13 Baihe Group
- 8.13.1 Baihe Group Company Information
- 8.13.2 Baihe Group Business Overview
- 8.13.3 Baihe Group Plant-based Soft Capsules (Softgel) Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.13.4 Baihe Group Plant-based Soft Capsules (Softgel) Product Portfolio
- 8.13.5 Baihe Group Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 Plant-based Soft Capsules (Softgel) Value Chain Analysis
- 9.1.1 Plant-based Soft Capsules (Softgel) Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Plant-based Soft Capsules (Softgel) Production Mode & Process
- 9.2 Plant-based Soft Capsules (Softgel) Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Plant-based Soft Capsules (Softgel) Distributors
- 9.2.3 Plant-based Soft Capsules (Softgel) Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
- 11.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst